1244 — 3D Medicines Share News
0.000.00%
Last trade - 00:00- HK$622.15m
- HK$233.49m
- CNY356.09m
Brief: 3D Medicines Inc Says Zhang Jing Resigns As CFO
Brief: 3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted
Brief: 3D Medicines Says Envafoimab Granted Orphan Drug Designation
Brief: 3D Medicines Inc Enters Strategic Agreement With Catug Biotechnology
Brief: 3D Medicines Says Court Approves Withdrawal Of Civil Proceedings By Qingdao Hainuo
Brief: 3D Medicines Updates On Strategic Cooperation Agreement
Brief: 3D Medicines Inc Have Not Received Further Civil Rulings From Court
Brief: 3D Medicines On Jan 15 Received A Civil Ruling
Brief: 3D Medicines Says CEO Purchased 20,000 Ordinary Shares
Brief: 3D Medicines Posts FY Revenue RMB634.9 Million
HK-listed Alphamab Oncology jumps most in 3 months on licence agreement
Brief: 3D Medicines Says License Agreement With Alphamab And Glenmark For Envafolimab
Brief: 3D Medicines Says Unit Agreed To Provide Short-Term Loan For RMB60 Mln
Brief: 3D Medicines Updates On Exclusive License Agreement Between Co And Sellas Life Sciences
Brief: 3D Medicines Says FDA Approval For Global Phase III Trial
China's 3D Medicines jumps on share buyback plan
Brief: 3D Medicines Inc - Proposed On-Market Share Repurchase Plan
Brief: 3D Medicines Notes Unusual Fluctuations In Price And Trading Volume Of Shares Of Company
China's 3D Medicines falls on discounted share sale